Michael Gibertini, President Clinical Development at INC Research Holdings, Inc. (INCR), sold 9,000 shares at $46.47 ($421K) on 2016-01-04, disclosed to the SEC on 2016-01-06.
Open-market sale of $421k INCR by President Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.47 | 5,900 | $274K | 65.1% |
| 2 | $47.52 | 3,100 | $147K | 34.9% |
| Total | $46.83 avg | 9,000 | $421K | 100% |
| Filing → |
| INCR | SELL | 2016-03-02 | $359K | — | Filing → |
| INCR | SELL | 2016-02-02 | $365K | — | Filing → |
| INCR | SELL | 2015-12-03 | $419K | — | Filing → |